We used ETA, a fusion protein consisting of two p75 TNF receptors bound to human IgG1receptor (Mohler et al., 1993) and currently used to treat autoimmune diseases like plaque psoriasis, psoriatic arthritis, ankylosing spondylitis among others. Here, TNFRSF1B is linked to autoimmune disease.